1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 708 F.Supp.3d
  5. 708 F.Supp.3d 486 (2023)
 

ZAPPIA v. MYOVANT SCIENCES LTD.

23-CV-8097 (JSR).

708 F.Supp.3d 486 (2023)

Joseph ZAPPIA, Individually and on Behalf of All Others Similarly Situated, Plaintiff, v. MYOVANT SCIENCES LTD., Myovant Sciences, Inc., Sumitomo Pharma America, Inc., Terrie Curran, Mark Guinan, David Marek, Nancy Valente, and Matthew Lang, Defendants.

United States District Court, S.D. New York.

Signed December 28, 2023.

Attorney(s) appearing for the Case

Joshua E. Fruchter, Wohl & Fruchter LLP, Monsey, NY, Joshua M. Rubin, Weiss & Lurie, New York, NY, Michael Allen Rogovin, Weiss Law, Atlanta, GA, for Plaintiff.

Boris Feldman, Elena Hadjimichael, Freshfields Bruckhaus Deringer U.S. LLP, Redwood City, CA, David Yury Livshiz, Nathan Hembree, Peter James Linken, Friedfields Bruckhaus Deringer U.S. LLP, New York, NY, for Defendants Sumitomo Pharma America, Inc., Terrie Curran, Mark Guinan, David Marek, Nancy Valente, Matthew Lang.

OPINION AND ORDER

In this putative class action, Lead Plaintiff Joseph Zappia alleges that Myovant Sciences Ltd. ("Myovant") and other defendants filed with the SEC a materially false and misleading proxy statement in connection with Myovant's acquisition, in violation of Rule 14a-9 promulgated...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases